(Q40214421)

18 September 2017

title

Structure of the Epstein-Barr virus major envelope glycoprotein (English)

1 reference

18 September 2017

0 references

3

1 reference

18 September 2017

7

V Michael Holers

1 reference

18 September 2017

1

Gerda Szakonyi

1 reference

18 September 2017

6

Rengasamy Asokan

1 reference

18 September 2017

Michael G Klein

2

1 reference

18 September 2017

Kendra A Young

series ordinal

4

1 reference

18 September 2017

Runlin Z Ma

series ordinal

5

1 reference

18 September 2017

Xiaojiang S Chen

series ordinal

8

1 reference

18 September 2017

publication date

29 October 2006

1 reference

Nature Structural & Molecular Biology

18 September 2017

published in

1 reference

18 September 2017

volume

13

1 reference

18 September 2017

issue

11

1 reference

18 September 2017

page(s)

996-1001

1 reference

https://scigraph.springernature.com/pub.10.1038/nsmb1161

18 September 2017

exact match

0 references

cites work

Progressive intrathoracic lymphadenopathy: EBV associated non-Hodgkin's lymphoma

1 reference

Epstein-Barr virus-associated lymphomas.

21 January 2018

1 reference

Epstein-Barr virus: 40 years on

21 January 2018

1 reference

Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2

21 January 2018

1 reference

Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis

21 January 2018

1 reference

Epstein-Barr virus (EBV) infection of murine L cells expressing recombinant human EBV/C3d receptor

21 January 2018

1 reference

Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells

21 January 2018

1 reference

Structure of the Epstein-Barr virus gp42 protein bound to the MHC class II receptor HLA-DR1

21 January 2018

1 reference

Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes

21 January 2018

1 reference

Structure of complement receptor 2 in complex with its C3d ligand

21 January 2018

1 reference

Kinetic analysis of the interactions of complement receptor 2 (CR2, CD21) with its ligands C3d, iC3b, and the EBV glycoprotein gp350/220.

21 January 2018

1 reference

Epitope Mapping Using the X-Ray Crystallographic Structure of Complement Receptor Type 2 (CR2)/CD21: Identification of a Highly Inhibitory Monoclonal Antibody That Directly Recognizes the CR2-C3d Interface

21 January 2018

1 reference

Determination of the structural basis for selective binding of Epstein-Barr virus to human complement receptor type 2

21 January 2018

1 reference

Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2.

21 January 2018

1 reference

Expression of Epstein-Barr virus gp350 as a single chain glycoprotein for an EBV subunit vaccine

21 January 2018

1 reference

Vero cell-expressed Epstein-Barr virus (EBV) gp350/220 protects marmosets from EBV challenge

21 January 2018

1 reference

Protective immunization against Epstein-Barr virus-induced disease in cottontop tamarins using the virus envelope glycoprotein gp340 produced from a bovine papillomavirus expression vector

21 January 2018

1 reference

Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity

21 January 2018

1 reference

Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28

21 January 2018

1 reference

Differential N-glycan patterns of secreted and intracellular IgG produced in Trichoplusia ni cells

21 January 2018

1 reference

Mutational analysis of the complement receptor type 2 (CR2/CD21)-C3d interaction reveals a putative charged SCR1 binding site for C3d.

21 January 2018

1 reference

X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2

21 January 2018

1 reference

The crystal structure of human CD21: Implications for Epstein-Barr virus and C3d binding

21 January 2018

1 reference

Identification of an epitope in the major envelope protein of Epstein-Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2).

21 January 2018

1 reference

Identification of three gp350/220 regions involved in Epstein-Barr virus invasion of host cells.

21 January 2018

1 reference

Conformation-dependent recognition of baculovirus-expressed Epstein-Barr virus gp350 by a panel of monoclonal antibodies

21 January 2018

1 reference

Distribution of epitopes within the amino acid sequence of the Epstein-Barr virus major envelope glycoprotein, gp340, recognized by hyperimmune rabbit sera

21 January 2018

1 reference

Antibody neutralization and escape by HIV-1

21 January 2018

1 reference

Automated MAD and MIR structure solution

21 January 2018

1 reference

[27] Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods.

21 January 2018

1 reference

Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination

21 January 2018

1 reference

Suppression of the Immune Response by a Soluble Complement Receptor of B Lymphocytes

21 January 2018

1 reference

Soluble recombinant CR2 (CD21) inhibits Epstein-Barr virus infection.

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NSMB1161

1 reference

18 September 2017

1 reference